F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review

2009 ◽  
Vol 70 (6) ◽  
pp. 468-472 ◽  
Author(s):  
R. Cohen ◽  
H. Bihan ◽  
G. des Guetz ◽  
P. Wind ◽  
A. Martin
Keyword(s):  
Literature Review ◽  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Fdg Pet ◽  
Colonic Cancer ◽  
Medullary Thyroid ◽  
Metastatic Colonic Cancer

Localization of Medullary Thyroid Carcinoma after Surgery Using11C-Methionine PET/CT: Comparison with18F-FDG PET/CT.

2010 ◽  
pp. P1-577-P1-577
Author(s):  
Hye Won Jang ◽  
Ji In Lee ◽  
Hee Kyung Kim ◽  
Seo Young Sohn ◽  
Sun Wook Kim ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Fdg Pet ◽  
Medullary Thyroid ◽  
Pet Ct ◽  
Fdg Pet Ct

scholarly journals Medullary Thyroid Carcinoma in a Patient with MEN 1 Syndrome. Case Report and Literature Review

2020 ◽  
Vol Volume 13 ◽  
pp. 7599-7603
Author(s):  
Alberto Friziero ◽  
Gianfranco Da Dalt ◽  
Andrea Piotto ◽  
Simone Serafini ◽  
Andrea Grego ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Medullary Thyroid ◽  
Men 1

Comparison of 68Ga-DOTATATE PET-CT, 18F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma

2015 ◽  
Vol 36 (3) ◽  
pp. 242-250 ◽  
Author(s):  
Zeynep G. Ozkan ◽  
Serkan Kuyumcu ◽  
Ayse Kubat Uzum ◽  
Mehmet F. Gecer ◽  
Sevda Ozel ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Fdg Pet ◽  
Medullary Thyroid ◽  
Dmsa Scintigraphy ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT

2009 ◽  
Vol 19 (6) ◽  
pp. 1425-1434 ◽  
Author(s):  
Mohsen Beheshti ◽  
Sigrid Pöcher ◽  
Reza Vali ◽  
Peter Waldenberger ◽  
Gabriele Broinger ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Fdg Pet ◽  
Medullary Thyroid ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

scholarly journals PET Imaging in Recurrent Medullary Thyroid Carcinoma

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Giorgio Treglia ◽  
Vittoria Rufini ◽  
Massimo Salvatori ◽  
Alessandro Giordano ◽  
Luca Giovanella
Keyword(s):  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Fdg Pet ◽  
Medullary Thyroid ◽  
Primary Surgery ◽  
Pet Tracer ◽  
Positron Emission ◽  
Pet Ct ◽  
Pet Radiopharmaceuticals

Purpose. To perform an overview about the role of positron emission tomography (PET) or PET/computed tomography (PET/CT) using different radiopharmaceuticals in recurrent medullary thyroid carcinoma (MTC) based on biochemical findings (increased tumor marker levels after primary surgery). Methods. A comprehensive literature search of studies published in PubMed/MEDLINE, Scopus, and Embase databases through February 2012 regarding PET or PET/CT in patients with recurrent MTC was performed. Results. Twenty-nine studies comprising 714 patients with suspected recurrent MTC were retrieved. Twenty-seven articles evaluated the role of fluorine-18-fluorodeoxyglucose (FDG) PET or PET/CT in recurrent MTC with conflicting results. Diagnostic accuracy of FDG-PET and PET/CT increased in MTC patients with higher calcitonin and carcinoembryonic antigen values, suggesting that these imaging methods could be very useful in patients with more advanced and aggressive disease. Eight articles evaluated the role of fluorine-18-dihydroxyphenylalanine (FDOPA) PET or PET/CT in recurrent MTC reporting promising results. Overall, FDOPA seems to be superior but complementary compared to FDG in detecting recurrent MTC. Few studies evaluating other PET tracers are also discussed. Conclusions. PET radiopharmaceuticals reflect different metabolic pathways in MTC. FDOPA seems to be the most useful PET tracer in detecting recurrent MTC based on rising levels of tumor markers. FDG may complement FDOPA in patients with more aggressive MTC.

scholarly journals Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib

2017 ◽  
Vol 59 (5) ◽  
pp. 756-761 ◽  
Author(s):  
Rudolf A. Werner ◽  
Jan-Stefan Schmid ◽  
Takahiro Higuchi ◽  
Mehrbod S. Javadi ◽  
Steven P. Rowe ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Predictive Value ◽  
Fdg Pet ◽  
Medullary Thyroid ◽  
18F Fdg
Sign in / Sign up

Export Citation Format

Share Document